Metabolic Engineering of Pseudomonas putida KT2440 to Produce Anthranilate from Glucose.

The Pseudomonas putida KT2440 strain was engineered in order to produce anthranilate (oAB, ortho-aminobenzoate), a precursor of the aromatic amino acid tryptophan, from glucose as sole carbon source. To enable the production of the metabolic intermediate oAB, the trpDC operon encoding an anthranilate phosphoribosyltransferase (TrpD) and an indole-3-glycerol phosphate synthase (TrpC), were deleted. In addition, the chorismate mutase (pheA) responsible for the conversion of chorismate over prephenate to phenylpyruvate was deleted in the background of the deletion of trpDC to circumvent a potential drain of precursor. To further increase the oAB production, a feedback insensitive version of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase encoded by the aroG (D146N) gene and an anthranilate synthase (trpE (S40F) G) were overexpressed separately and simultaneously in the deletion mutants. With optimized production conditions in a tryptophan-limited fed-batch process a maximum of 1.54 ± 0.3 g L(-1) (11.23 mM) oAB was obtained with the best performing engineered P. putida KT2440 strain (P. putida ΔtrpDC pSEVA234_aroG (D146N) _trpE (S40F) G).

Introduction

Anthranilate (oAB, ortho-aminobenzoate) is an aromatic acid used as a platform chemical for the production of food ingredients (Raffensperger and Vogt, 1961), dyes, perfumes (Wiklund and Bergman, 2006), crop protection compounds (Askham, 1992; Yadav and Krishnan, 1998; Chambers et al., 2013), pharmaceutical compounds (Bahia et al., 2011; Shafiq et al., 2011; Haynes et al., 2012; Gao et al., 2013; Loque and Weniger, 2013; Walsh et al., 2013), and plastics such as nylon (Sun et al., 2013). It is currently produced in energy intensive chemical processes from petroleum-based precursors, like phthalamic acid (Klipper and Gripper, 1981; Berg, 2009). Furthermore, the production of the precursors and the production of oAB accumulate toxic byproducts, such as hypochlorite which is used with molar equivalency to oAB (Berg, 2009). Thus, there is a strong motivation to find alternative routes to produce platform chemicals, such as oAB, in green production processes from renewable resources in an environmental friendly way. In addition, the development and application of green production processes is accelerated by an environmental and political interest to be less dependent on fossil resources.

Biocatalysis using living microbes as catalysts is a well-established alternative for the production of chemicals. The aromatic biosynthesis pathway and the derived compounds of the aromatic acids, such as oAB, have been intensively studied in the last decades (Bongaerts et al., 2001; Ikeda, 2003; Kramer et al., 2003; Leuchtenberger et al., 2005; Pittard and Yang, 2008). Microbial production of oAB with engineered Escherichia coli strains was reported by Balderas-Hernandez et al. (2009) followed by further publications on oAB-derived compounds such as catechol and muconic acid (Sun et al., 2013; Averesch and Krömer, 2014; Balderas-Hernandez et al., 2014; Jaeger et al., 2015). To enable oAB production in E. coli, Balderas-Hernandez et al. (2009, 2014) inserted a point mutation in the oAB phosphoribosyl transferase domain (trpD), whereas Sun et al. (2013) used the Keio collection deletion strain E. coli BW25113 Δtrp::kan to prevent the conversion of oAB to tryptophan. Additional targets to increase the production of oAB in E. coli, for example the overexpression of feedback insensitive variants of the 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP) synthase and the anthranilate synthase unit (trpE) were investigated. A maximum titer of 14 g L-1 oAB was reported growing the engineered strains in complex medium containing 30 g L-1 yeast extract (Balderas-Hernandez et al., 2009).

Here, we present the first attempt of microbial production of oAB from glucose as sole carbon source with an engineered P seudomonas putida KT2440 strain. Due to its versatile metabolism and low nutritional requirements P. putida is an efficient production strain for various industrial relevant products (Tiso et al., 2014). In addition its high biomass yield, high growth rate, and low maintenance demand fulfill the rigorous demands of industrial biotechnology (Poblete-Castro et al., 2012). A broad portfolio of P. putida biocatalysts for bulk chemicals such as phenol (Wierckx et al., 2005), p-hydroxystyrene (Verhoef et al., 2009), p-hydroxybenzoate (Verhoef et al., 2007), rhamnolipids (Wittgens et al., 2011), polyhydroxyalkanoates (PHA; Wang et al., 2011), and (S)-styrene oxide (Blank et al., 2008) demonstrate the great potential of this species as a flexible cell factory for the production of chemicals in industrial biotechnology. In addition, P. putida strains have the capability to withstand various chemical stresses such as a second phase of toluene, octanol, or styrene (Heipieper and de Bont, 1994; Dominguez-Cuevas et al., 2006; Blank et al., 2008), as well as oxidative stress (Chavarria et al., 2013) and reduced water activity (Hallsworth et al., 2003), and thus providing a promising and versatile chassis for the production of toxic compounds such as oAB.

To ensure industrially relevant oAB production conditions a full, markerless deletion of trpDC was performed in P. putida, facilitated by the fact that in contrast to E. coli the trpEG and trpDC genes are encoded by separate open reading frames. Additionally the production of oAB was realized on glucose as sole carbon source, avoiding the addition of high amounts of complex media components such as yeast extract. A maximum titer of 1.54 ± 0.3 g L-1 (11.23 mM) oAB was obtained with the best performing engineered P. putida KT2440 strain (P. putida ΔtrpDC pSEVA234_aroG) in tryptophan-limited fed-batch fermentations with glucose as sole carbon source.

Materials and Methods

Strains and Plasmids

The deletion of trpDC and pheA were performed by a clean and markerless deletion method described by Martinez-Garcia and de Lorenzo (2011) resulting in two knock out strains P. putida KT2440 trpDC and P. putida KT2440 trpDC pheA. To obtain the knockout vectors pEMG_ΔtrpDC and pEMG_ΔpheA were obtained via a standard restriction and ligation approach and were transformed into chemical competent E. coli DH5α (according to Choi et al., 2006) via electroporation. The 800-bp flanks upstream (TS1) and downstream (TS2) of the gene of interest (trpDC and pheA) were amplified by PCR using a Pfu polymerase (New England Biolabs) with the primers listed in Table .

TS1 and TS2 were fused in a SOEing-PCR using Pfu polymerase according to Horton (1995). The backbone (pEMG) and the fused SOEing-PCR fragment were digested with BamHI and EcoRI for the deletion of trpDC and with BamHI and SbfI for the deletion of pheA. The digested backbones, TS1, and TS2 were purified (High Pure PCR Product Purification Kit, Roche), ligated with a T4 DNA ligase (Thermo Fisher Scientific) and transformed into chemical competent E. coli DH5α (according to Choi et al., 2006) via electroporation. Constructs were verified by restriction analysis and sequencing, resulting in pEMG_ΔtrpDC and pEMG_ΔpheA. Genome integration of the knockout constructs into the P. putida strains was performed via tri-parental mating according to Ditta et al. (1980) using E. coli HB101 pRK2013 as the helper strain and facilitated as described in Zobel et al. (2015) where the three mating strains were streaked one above the other on a LB plate. The resulting strains were transformed with the plasmid expressing the ISce-I endonuclease (pSW-I; according to Choi et al., 2006). Induction with 3-methylbenzoate was omitted due to the leaky expression of the ISce-I nuclease. Successful construction of the knockout strains was verified via restriction, PCR and Sanger sequencing.

The feedback insensitive overexpression constructs were obtained via a standard restriction and ligation approach as described above using BamHI and EcoRI for aroG and BamHI for trpE. pSEVA234 (Silva-Rocha et al., 2013), which contains an IPTG inducible lacIQ-Ptrc expression system, was used as backbone. The genes aroG (Kikuchi et al., 1997; Albermann et al., 2014) and trpE (Kwak et al., 1999) were synthesized at Eurofins Genomics. A summary of the used and constructed plasmids and of the engineered strains is shown in Table . All primers were purchased at Eurofins Genomics and all restriction enzymes at Thermo Fisher Scientific.

Cultivation Conditions

For cloning and maintenance processes, E. coli strains and P. putida strains were cultivated at 37 and 30°C, respectively, in LB medium supplemented with or without kanamycin (50 mg L-1) or ampicillin (100 mg L-1 for E. coli and 500 mg L-1 for P. putida), and/or with 1.5% (w/v) agar as needed.

Auxotrophies (tryptophan and phenylalanine) of the gene deletion mutants were verified on solid mineral medium plates (Wierckx et al., 2005) with 1.5% (w/v) agar, 20 mM glucose with and without 1 mM tryptophan, and/or 1 mM phenylalanine supplementation. Alternatively 1 mM phenylpyruvate was used instead of phenylalanine.

Batch-wise oAB production was performed in 500 mL shake flasks at 30°C and 200 rpm in 50 mL mineral medium as described in Wierckx et al. (2005) with 20 mM glucose (unless stated differently), 50 mg L-1 kanamycin, and 1 mM IPTG, supplemented with either 0.1 or 0.05 mM tryptophan and 1 mM phenlypyruvate for the ΔpheA strains. Two additional 20 mM glucose pulses were added after 10 and 24 h unless stated differently.

Tryptophan-limited fed-batch conditions were realized in controlled bioreactors (BioFlo 110 or BioFlo 115, Eppendorf / New Brunswick Scientific) with a starting volume of 400 mL. The initial fermentation medium consisted of mineral medium with 50 mM glucose, a twofold phosphate buffer concentration, a threefold (NH4)2SO4 concentration, a onefold trace element solution, 1 mM IPTG, 50 mM kanamycin, and 0.1 mM tryptophan. After the initial batch phase, the feed was switched on at a rate of 2 mL h-1 consisting of a mixed solution of 1 M glucose and 0.5 mM (glucose to tryptophan molar ratio of 2,000:1) or 1 mM (glucose to tryptophan molar ratio of 1,000:1) tryptophan. To compensate for the increasing biomass concentrations the 1 mM tryptophan feed was increased to 6 mL h-1. The fermentations were performed at 30°C, with 500–1,200 rpm agitation (dO2 regulated agitation cascade with a lower limit of 35%), with 1 vvm headspace aeration of compressed air. The pH was regulated to pH = 7 with 2 M KOH and 4 M H2SO4.

Analytics

The biomass concentration was measured with a spectrophotometer (Ultrospec 10, GE Healthcare Life Sciences). In this device the OD600 correlates to cell dry weight (CDW): 1 OD600 = 0.505 gCDW L-1. The samples taken during cultivation were centrifuged at 13,300 rpm for 3 min and stored at -20°C for further analysis. To follow the consumption of the glucose and derivatives (gluconate and 2-ketogluconate) by the P. putida KT2440 strains, a Beckman HPLC equipped with an organic acid resin column (polystyrol-divinylbenzol copolymer, PS-DVB: 300 × 8.0 mm, CS-Chromatographie) was used with 5 mM H2SO4 as eluent at a flow of 0.8 mL h-1 for 11 min at 75°C. Detection was realized with an UV detector at a wavelength of 210 nm and a RI detector. The oAB production was analyzed with a reverse phase column (LiChrosorb 100 RP-18, 250 × 4 mm, Merck), at a flow of 1.2 mL h-1 [pump gradient of H2O + 0.1% TFA (pump A) and of MeOH (pump B): 0–2 min 90% A, 2–12 min gradient 0–90% A, 12–14 min 0% A, 14–15 min gradient 0–90% A, and 15–16 min 90% A] at 30°C. Detection was realized with an UV detector at a wavelength of 257 nm and a RI detector.

Results and Discussion

Metabolic Engineering of oAB Production Strains

In order to establish oAB production in P. putida, the trpDC and pheA genes were knocked out using the I-SceI-based pEMG system (Martinez-Garcia and de Lorenzo, 2011). Disruption of the trpDC genes, which encode an anthranilate phosphoribosyltransferase (TrpD) and an indole-3-glycerol phosphate synthase (TrpC), leads to a tryptophan auxotrophy and enables the accumulation of oAB (Figure ). Disruption of the pheA gene, which encodes a bifunctional chorismate mutase/prephenate dehydratase enzyme responsible for the first two steps of the synthesis of phenylalanine and tyrosine, possibly increases the metabolic flux toward oAB by reducing the drain on its primary precursor chorismate (Zhao et al., 2011). Contrary to other established production hosts, the pheA deletion only requires phenylalanine to complement growth since P. putida can convert phenylalanine to tyrosine (Molina-Henares et al., 2009). The corresponding auxotrophies were verified on mineral medium plates (Table ).

Schematic oAB production pathway including the metabolic engineering targets investigated in this study (overexpression of PEP, phosphoenolpyruvate; E4P, erythrose-4-phosphate; DAHP, 3-Deoxy-D-arabinoheptulosonate-7-phosphate.

In the knockout process, the deletion of pheA could only be obtained by supplementation with phenylpyruvate. The final step of the knockout procedure (induction of the double strand break) should theoretically yield a one-to-one ratio of wildtype to knockout allele. However, selection on LB- or LB medium with phenylalanine resulted in the wildtype allele only, even after testing >1,000 colonies either by PCR or by screening for phenylalanine auxotrophy. This may be attributed to the ability of P. putida to degrade phenylalanine and tyrosine. Possibly, supplementation with phenylpyruvate instead of phenylalanine reduced the induction of genes encoding the phenylalanine and tyrosine catabolic pathway (Arias-Barrau et al., 2004), facilitating the successful isolation of the knockout strain. The final pheA knockout auxotroph could be complemented with phenylalanine in mineral medium. However, in this case a severe negative effect on the fitness of the mutant caused by the deletion of pheA was observed. Therefore, all subsequent ΔpheA complementation were done with phenylpyruvate.

To further optimize the production of oAB in P. putida, feedback insensitive pSEVA234-based (Silva-Rocha et al., 2013) overexpression constructs for trpE and aroG, or both genes in one operon structure, were transformed to the respective mutants under the IPTG-inducible LacIQ-Ptrc system. These genes encode feedback insensitive variants of anthranilate synthase and 3-deoxy-D-arabino-heptulosonate-7-phosphate (DHAP) synthase, respectively, and are known to enhance oAB production in E. coli (Balderas-Hernandez et al., 2009, 2014; Sun et al., 2013). Figure shows the exemplarily oAB production pathway and gives on overview over the metabolic engineering targets investigated in this study.

Evaluation of oAB Production Strains in Shake Flasks

The P. putida strains engineered for the production of oAB (listed in Table ) were initially assessed in shake flasks (Figures ) and under slightly optimized production conditions a maximum titer of 0.25 ± 0.004 g L-1 (1.83 mM) oAB with glucose as sole carbon source was achieved (Figure ). The three ΔtrpDC strains bearing either trpE, aroG or both, have shown no significant differences in maximal oAB titers, although the onset of production was earlier in the P. putida KT2440 ΔtrpDC pSEVA234_aroG_trpE. Interestingly, oAB production was also observed with P. putida KT2440 pSEVA234_aroG_trpE (without trpDC deletion) while no tryptophan was secreted, although the maximal titer was lower than that of the ΔtrpDC strains. This can be explained by the transcriptional repression of trp genes by tryptophan through the TrpR repressor (Maurer and Crawford, 1971; Wierckx et al., 2008). Likely, an increase of intracellular tryptophan caused repression of the native trp genes, leading to anthranilate accumulation due to the heterologous expression of trpE.

oAB production profiles of various Biomass growth (A) and oAB production (B) of the following Pseudomonas putida KT2440 strains in an initial screening experiment: , ΔtrpDC pSEVA234_trpE; , ΔtrpDC pSEVA234_aroG; , ΔtrpDC pSEVA234_aroG; , ΔtrpDC ΔpheA pSEVA234_trpE; , ΔtrpDC ΔpheA pSEVA234_aroG; , ΔtrpDC ΔpheA pSEVA234_aroG; , pSEVA234_aroG. All cultures were performed in mineral medium with 20 mM initial glucose concentration and addition of tryptophan and/or phenylpyruvate as described above. The arrows indicate the addition of glucose to a concentration of 20 mM.

Detailed profiles of All cultures were performed in mineral medium with 20 mM initial glucose concentration and addition of tryptophan and/or phenylpyruvate as described above. The arrows indicate the addition of glucose to a concentration of 20 mM.

A strong connection was observed between tryptophan limitation and oAB production. When supplementing the auxotrophic strains with tryptophan the oAB production was induced only upon depletion of the added tryptophan. Strains expressing both aroG and trpE produced oAB at earlier time points compared to strains with only one of the feedback insensitive genes, indicating somewhat alleviated feedback insensitivity to tryptophan (Figure ). With the non-auxotrophic P. putida pSEVA234_aroG_trpE, where a supplementation with tryptophan was not required, oAB titers were significantly higher at earlier time points, indicating no inhibition by tryptophan. However, the final oAB titers were 34% lower compared to the P. putida ΔtrpDC strains, indicating a positive effect of the deletion of trpDC.

As indicated above, a clear negative effect of the deletion of pheA on the growth behavior was observed. Whereas P. putida KT2440 pSEVA234_trpE and P. putida KT2440 ΔtrpDC pSEVA234_trpE were able to grow up to 3.6 g L-1 CDW and 2.4 g L-1 CDW, respectively; P.putida KT2440 ΔtrpDC ΔpheA pSEVA234_trpE only reached a maximal CDW concentration of 1.4 g L-1 after 10 hours when supplemented with 1 mM phenylpyruvate. Further addition of glucose and/or tryptophan could neither initiate growth to higher CDW concentrations, nor did it improve oAB production. Normal growth was only fully rescued when supplementing high amounts of phenylpyruvate (≥5 mM) which would make the overall process highly uneconomical. Additionally, final oAB titers were still 49% lower than with the ΔtrpDC strains, indicating a negative effect of the pheA deletion for the production of oAB in this organism. Thus, the most promising strain engineered for the production of oAB is P. putida ΔtrpDC pSEVA234_aroG_trpE as it reached high titers of oAB and showed reduced sensitivity to tryptophan.

Dehydroshikimate, a metabolic intermediate of the shikimate pathway and thus a precursor of oAB, accumulated as a by-product in all strains engineered for oAB production in shake flasks, indicating shikimate dehydrogenase as a likely bottleneck (Figure ). This hypothesis is also supported by the transcriptome data sets of Wierckx et al. (2009) and Verhoef et al. (2010) showing upregulated 3-dehydroquinate and dehydroshikimate genes in the analyzed phenol and p-hydroxybenzoate production strains obtained by a fluoro-analog mutant screening.

Production of oAB in Controlled Bioreactors

The potential of P. putida ΔtrpDC pSEVA234_aroG_trpE to produce oAB was further assessed in tryptophan-limited fed batch cultures to circumvent the observed inhibition by tryptophan and maximize final oAB titers. A glucose-to-tryptophan molar ratio of 400:1 was estimated for biomass growth alone based on the initial shake flask experiments. Therefore, two different feeding approaches with a molar ratio of glucose to tryptophan of 1,000:1 and 2,000:1 were used to ensure a tryptophan limitation without excessive accumulation of glucose or its derivatives. Under these conditions a maximal titer of 1.54 ± 0.3 g L-1 oAB was reached from glucose as sole carbon source using the 2,000:1 feed (Figure ). The higher ratio of glucose to tryptophan led to a more severe growth limitation, with CDW increasing only marginally during the production of oAB. In contrast, the 1,000:1 feed enabled more biomass growth at the cost of oAB production, leading to a final product titer of 1.0 ± 0.07 g L-1. The product per substrate yield (based on consumed carbon source) for both conditions is relatively similar at 3.6 ± 0.5% (g/g) for the 1,000:1 feed and 3.5 ± 0.5% (g/g) for the 2,000:1 feed. oAB levels increased fairly linearly until the production stopped abruptly. Since the level of oAB produced is well below growth-inhibiting concentrations for P. putida (data not shown), oAB production is most likely stopped due to product inhibition, a known phenomenon for the production of aromatics (Gibson and Pittard, 1968; Wierckx et al., 2008; Rodriguez et al., 2014). This product inhibition likely takes place at the level of the anthranilate synthase. Indeed, the anthranilate synthase complex of other organisms is already inhibited by oAB concentrations in the micromolar range (Cordaro et al., 1968; Henderson et al., 1970; Francis et al., 1978). The oAB titers obtained with P. putida KT2440 in this study are about 10-fold lower than those achieved by Balderas-Hernandez et al. (2009). The difference can most likely be attributed to the supplementation of 30 g/L yeast extract by these researchers, which can provide oAB precursors and increases the general stress tolerance of microorganisms. This apparent positive effect of yeast extract on oAB production should be further investigated in order to elucidate the responsible components.

Tryptophan-limited fed-batch cultures of Feed molar ratio of glucose to tryptophan 1,000:1. (B) Feed molar ratio of glucose-to-tryptophan 2,000:1. , cell dry weight; , oAB concentration. The arrows indicate the start of the feed after the initial batch phase.

In the initial batch phase, the 50 mM glucose were entirely consumed for the production of biomass. Tryptophan limiting conditions were confirmed by HPLC analysis throughout the fermentation (<0.1 mM). Carbon source, either as glucose or as gluconate and 2-ketogluconate, were constantly present during the feed phase at total concentrations between 0.4 and 8.6 g L-1. In some fermenters, a prolonged incubation led to a decrease of oAB concentrations over time. Possibly, polymerization of oAB and/or its conversion products occurred.

Conclusion

Microbial production of oAB under industrial relevant conditions from glucose as sole carbon source was achieved in P. putida KT2440 via the biosynthesis pathway of aromatic amino acids. A strong connection between a tryptophan limitation and oAB production was observed even with strains bearing feedback insensitive overexpression constructs of aroG and trpE. Under tryptophan limiting fed-batch conditions, a maximum titer of 1.54 ± 0.3 g L-1 oAB was achieved with P. putida KT2440 ΔtrpDC pSEVA234_aroG_trpE. This final achieved concentration is in the same range as other aromatics produced by P. putida strains (Nijkamp et al., 2005, 2007; Verhoef et al., 2007); although the titer is lower than that of previously published works with E. coli (Balderas-Hernandez et al., 2009). However, the supplementation with yeast extract was avoided and oAB was only produced from glucose. In addition, to ensure long term strain stability, one of the main requirements in industrial biotechnology, a stable and markerless deletion of the genes responsible for the conversion of oAB towards tryptophan (trpDC) was used. Nevertheless, the oAB titer and yield reached with P. putida KT2440 are below those which are required to realize an industrial feasible process. Further improvement is required, e.g., by more in-depth metabolic engineering (e.g., overexpression of tkt: Balderas-Hernandez et al., 2009) as well as by in situ product removal to alleviate product inhibition. Further research on the mechanism of product inhibition of oAB production could also lead to additional metabolic engineering targets to improve microbial oAB production.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Table 1

Primer sequences.

Name	DNA sequence	Tm (°C)
TS1 ΔtrpDC
JK034f	agggataacagggtaatctgaatTCGTCAGCAAACTCTTGATG	61.6
JK035r	tttgactcgagGTTCGATCCTTAACGGCG	61.6
TS2 ΔtrpDC
JK036f	aggatcgaacctcgagTCAAATGAAGCCGGCGTT	66.1
JK037r	cctgcaggtcgactctagaggatccTCGAACCAAGGTGCTACCG	66.1
TS1 ΔpheA
JK038f	attcgagctcggtacccggggatccACTACATCGAAACCGGCATC	61.8
JK039r	ctgaactcgagTCAGCCATGCTCCTTCTC	61.8
TS2 ΔpheA
JK040f	gcatggctgactcgagTTCAGGGGCCTTGGGGCT	70.2
JK041r	tagaagcttgcatgcctgcaggCAGTGAGTCGACCAGGCCAAAG	70.2

Table 2

Summary of plasmids and strains used in this study.

	Description	Reference
Plasmids
pEMG	KmR, oriR6K, lacZa with two flanking I-SceI sites	Martinez-Garcia and de Lorenzo, 2011
pSEVA234	KmR, oriBBR1, lacIq-Ptrc	Silva-Rocha et al., 2013
pSW-I	ApR, oriRK2, xylS, Pm→I-SceI	Martinez-Garcia and de Lorenzo, 2011
pRK2013	KmR, oriRK2, oriColE1	Figurski et al., 1979
pEMG_ΔtrpDC	trpDC deletion plasmid	This work
pEMG_ΔpheA	pheA deletion plasmid	This work
pSEVA234_trpES40FG	trpES40FG expression plasmid	This work
pSEVA234_aroGD146N	aroGD146N expression plasmid	This work
pSEVA234_aroGD146N_trpES40FG	aroGD146N-trpES40FG expression plasmid	This work
Strain
Psuedomonas putida KT2440	Wild-type strain derived of P. putida mt-2 cured of the pWW0 plasmid	Bagdasarian et al., 1981
Escherichia coli DH5α	supE44, DlacU169 (f80 lacZDM15), hsdR17 (rk-mk+), recA1, endA1, thi1, gyrA, relA	Hanahan, 1985
E. coli DH5α aaapir	aaapir phage lysogen of DH5α	De Lorenzo Lab collection
E. coli HB101 pRK2013	SmR, hsdR-M+, pro, leu, thi, recA, KmR, oriRK2, oriColE1	Figurski et al., 1979
E. coli DH5α aaapir pEMG	Plasmid carrier strain	Martinez-Garcia and de Lorenzo, 2011
E. coli DH5α aaapir pSW-I	Plasmid carrier strain	Martinez-Garcia and de Lorenzo, 2011
E. coli DH5α aaapir pEMG_ΔtrpDC	Plasmid carrier strain	This work
E. coli DH5α aaapir pEMG_ΔpheA	Plasmid carrier strain	This work
E. coli DH5α pSEVA234_trpES40FG	Plasmid carrier strain	This work
E. coli DH5α pSEVA234_aroGD146N	Plasmid carrier strain	This work
E. coli DH5α pSEVA234_aroGD146N_trpES40FG	Plasmid carrier strain	This work
P. putida KT2440 pSEVA234_trpES40FG	oAB production strain	This work
P. putida KT2440 pSEVA234_aroGD146N	oAB production strain	This work
P. putida KT2440 pSEVA234_aroGD146N_trpES40FG	oAB production strain	This work
P. putida KT2440 ΔtrpDC	oAB production strain	This work
P. putida KT2440 ΔtrpDC pSEVA234_trpES40FG	oAB production strain	This work
P. putida KT2440 ΔtrpDC pSEVA234_aroGD146N	oAB production strain	This work
P. putida KT2440 ΔtrpDC pSEVA234_aroGD146N_trpES40FG	oAB production strain	This work
P. putida KT2440 ΔtrpDC ΔpheA	oAB production strain	This work
P. putida KT2440 ΔtrpDC ΔpheA pSEVA234_trpES40FG	oAB production strain	This work
P. putida KT2440 ΔtrpDC ΔpheA pSEVA234_aroGD146N	oAB production strain	This work
P. putida KT2440 ΔtrpDC ΔpheA pSEVA234_aroGD146N_trpES40FG	oAB production strain	This work

Table 3

Auxotrophy supplementation of P. putida KT2440 ΔtrpDC and ΔpheA knockouts.

Name	Supplementationa	Growth
P. putida KT2440	None	+
	trp	+
	phe	+
	trp + phe	+
P. putida KT2440 ΔtrpDC	None	-
	Trp	+
P. putida KT2440 ΔtrpDC ΔpheA	None	-
	Trp	-
	trp + phe	+
	trp + pp	+